Oncotarget, 1949-2553


  1. 2020
  2. 2019
  3. 2018
  4. Singh, A. A., Petraglia, F., Nebbioso, A., Yi, G., Conte, M., Valente, S., ... Martens, J. H. A. (2018). Multi-omics profiling reveals a distinctive epigenome signature for high-risk acute promyelocytic leukemia. Oncotarget, 9(39), 25647-25660. https://doi.org/10.18632/oncotarget.25429
  5. Li, Y., Finkbeiner, S., Ganner, A., Gerber, J., Klein, M., Grafe, M., ... Neumann-Haefelin, E. (2018). CGEF-1 regulates mTORC1 signaling during adult longevity and stress response in. Oncotarget, 9(11), 9581-9595. https://doi.org/10.18632/oncotarget.24039
  6. Petraglia, F., Singh, A. A., Carafa, V., Nebbioso, A., Conte, M., Scisciola, L., ... Altucci, L. (2018). Combined HAT/EZH2 modulation leads to cancer-selective cell death. Oncotarget, 9(39), 25630-25646. https://doi.org/10.18632/oncotarget.25428
  7. 2017
  8. Gleissner, L., Kwiatkowski, M., Myllynen, L., Steffen, P., Petersen, C., Rothkamm, K., ... Kriegs, M. (2017). Analyzing the influence of kinase inhibitors on DNA repair by differential proteomics of chromatin-interacting proteins and nuclear phospho-proteins. Oncotarget, 8(67), 110983-110993. https://doi.org/10.18632/oncotarget.22424
  9. Kohli, J. S., Mir, H., Wasif, A., Chong, H., Akhras, V., Kumar, R., ... Bennett, D. C. (2017). ETS1, nucleolar and non-nucleolar TERT expression in nevus to melanoma progression. Oncotarget, 8(61), 104408-104417. https://doi.org/10.18632/oncotarget.22254
  10. Dias, F., Teixeira, A. L., Ferreira, M., Adem, B., Bastos, N., Vieira, J., ... Medeiros, R. (2017). Plasmatic miR-210, miR-221 and miR-1233 profile: Potential liquid biopsies candidates for renal cell carcinoma. Oncotarget, 8(61), 103315-103326. https://doi.org/10.18632/oncotarget.21733
  11. Bongaarts, A., Giannikou, K., Reinten, R. J., Anink, J. J., Mills, J. D., Jansen, F. E., ... Aronica, E. (2017). Subependymal giant cell astrocytomas in Tuberous Sclerosis Complex have consistent TSC1/TSC2 biallelic inactivation, and no BRAF mutations. Oncotarget, 8(56), 95516-95529. https://doi.org/10.18632/oncotarget.20764
  12. Cano-Rodriguez, D., Campagnoli, S., Grandi, A., Parri, M., De Camilli, E., Song, C., ... Grifantini, R. (2017). TCTN2: a novel tumor marker with oncogenic properties. Oncotarget, 8(56), 95256-95269. https://doi.org/10.18632/oncotarget.20438
  13. Liang, Y-K., Lin, H-Y., Chen, C-F., & Zeng, D. (2017). Prognostic values of distinct CBX family members in breast cancer. Oncotarget, 8(54), 92375-92387. https://doi.org/10.18632/oncotarget.21325
  14. Zamanian-Daryoush, M., Lindner, D. J., DiDonato, J. A., Wagner, M., Buffa, J., Rayman, P., ... Hazen, S. L. (2017). Myeloid-specific genetic ablation of ATP-binding cassette transporter ABCA1 is protective against cancer. Oncotarget, 8(42), 71965-71980. https://doi.org/10.18632/oncotarget.18666
  15. Skalniak, L., Zak, K. M., Guzik, K., Magiera, K., Musielak, B., Pachota, M., ... Holak, T. A. (2017). Small-molecule inhibitors of PD-1/PD-L1 immune checkpoint alleviate the PD-L1-induced exhaustion of T-cells. Oncotarget, 8(42), 72167-72181. https://doi.org/10.18632/oncotarget.20050
  16. Mahmud, H., Scherpen, F. J. G., Meeuwsen de Boer, T., Lourens, H-J., Schoenherr, C., Eder, M., ... de Bont, E. S. (2017). Peptide microarray profiling identifies phospholipase C gamma 1 (PLC-γ1) as a potential target for t(8;21) AML. Oncotarget, 8(40), 67344-67354. https://doi.org/10.18632/oncotarget.18631
  17. de Groot, J. S., van Diest, P. J., van Amersfoort, M., Vlug, E. J., Pan, X., ter Hoeve, N. D., ... Derksen, P. W. B. (2017). Intraductal cisplatin treatment in a BRCA-associated breast cancer mouse model attenuates tumor development but leads to systemic tumors in aged female mice. Oncotarget, 8(37), 60750-60763. https://doi.org/10.18632/oncotarget.18490
  18. Weeber, F., Cirkel, G. A., Hoogstraat, M., Bins, S., Gadellaa-van Hooijdonk, C. G. M., Ooft, S., ... Voest, E. E. (2017). Predicting clinical benefit from everolimus in patients with advanced solid tumors, the CPCT-03 study. Oncotarget, 8(33), 55582-55592. https://doi.org/10.18632/oncotarget.16029
  19. Fabrizio, F. P., Costantini, M., Copetti, M., la Torre, A., Sparaneo, A., Fontana, A., ... Fazio, V. M. (2017). Keap1/Nrf2 pathway in kidney cancer: frequent methylation of KEAP1 gene promoter in clear renal cell carcinoma. Oncotarget, 8(7), 11187-11198. https://doi.org/10.18632/oncotarget.14492
  20. Lodewijk, L., van Diest, P., van der Groep, P., ter Hoeve, N., Schepers, A., Morreau, J., ... Vriens, M. (2017). Expression of HIF-1 alpha in medullary thyroid cancer identifies a subgroup with poor prognosis. Oncotarget, 8(17), 28650-28659. https://doi.org/10.18632/oncotarget.15622
  21. 2016
  22. Matondo, R. B., Toussaint, M. J. M., Govaert, K. M., van Vuuren, L. D., Nantasanti, S., Nijkamp, M. W., ... de Bruin, A. (2016). Surgical resection and radiofrequency ablation initiate cancer in cytokeratin-19(+)- liver cells deficient for p53 and Rb. Oncotarget, 7(34), 54662-54675. https://doi.org/10.18632/oncotarget.9952
  23. Guerrero-Preston, R., Godoy-Vitorino, F., Jedlicka, A., Rodriguez-Hilario, A., Gonzalez, H., Bondy, J., ... Sidransky, D. (2016). 16S rRNA amplicon sequencing identifies microbiota associated with oral cancer, Human Papilloma Virus infection and surgical treatment. Oncotarget, 7(32), 51320-51334. https://doi.org/10.18632/oncotarget.9710
  24. Zak, K. M., Grudnik, P., Guzik, K., Zieba, B. J., Musielak, B., Dömling, A., ... Holak, T. A. (2016). Structural basis for small molecule targeting of the programmed death ligand 1 (PD-L1). Oncotarget, 7(21), 30323-30335. https://doi.org/10.18632/oncotarget.8730
Previous 1 2 Next

ID: 5996107